Skip to content
Screener

Veracyte VCYT Net Income

Net Income at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
-$34.1M-34,000%
Biodesix, Inc. logo
Biodesix, Inc.BDSX
-$7.27M+36.6%
Castle Biosciences logo
Castle BiosciencesCSTL
-$14.52M+43.8%
Personalis, Inc. logo
Personalis, Inc.PSNL
-$30.03M-90.7%
Guardant Health logo
Guardant HealthGH
-$112.08M-17.8%
Natera, Inc. logo
Natera, Inc.NTRA
-$66.97M+33.7%

Segments

By segment

See full
Reportable Segment$28.71M+307%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$3.71B+97.6%
Enterprise value$3.48B+104%
P/E42.2×-29.1×
P/S6.9×+2.9×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The source filing: Veracyte’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 8:07 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001384101-26-000031
Line itemThree Months Ended March 31, 20262025
Other income, net7,3284,524
Income before income taxes29,9747,428
Income tax provision1,267381
Net income$28,707$7,047
Earnings per share:
Basic$0.36$0.09
Diluted$0.35$0.09
Shares used to compute earnings per common share:

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Veracyte's net income?
Veracyte (VCYT) reported net income of $28.71M in Q1 2026.
How has Veracyte's net income changed year-over-year?
Veracyte's net income increased by 307.4% year-over-year, from $7.05M to $28.71M.
What is the long-term trend for Veracyte's net income?
Over 4 years (2021 to 2025), Veracyte's net income has grown at a -3.2% compound annual growth rate (CAGR), from -$75.56M to $66.35M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Ask your AI about Veracyte's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude